Overview
Mano Horinaka practices in Kyoto, Japan. Mr. Horinaka is rated as an Experienced expert by MediFind in the treatment of Keloids. His top areas of expertise are Retinoblastoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Familial Adenomatous Polyposis.
His clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Keloids.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMr. Horinaka isExperienced. Learn about Breast Cancer.
- Colorectal CancerMr. Horinaka isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerMr. Horinaka isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Adenomatous PolyposisMr. Horinaka isExperienced. Learn about Familial Adenomatous Polyposis.
- Familial Colorectal CancerMr. Horinaka isExperienced. Learn about Familial Colorectal Cancer.
- FibrosarcomaMr. Horinaka isExperienced. Learn about Fibrosarcoma.